Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Eastern Cooperative Oncology Group
Protara Therapeutics
Protara Therapeutics
Institut Claudius Regaud
CG Oncology, Inc.
University of Pittsburgh
Medical University of Vienna
Medical University of Vienna
University of Arizona
M.D. Anderson Cancer Center
Rigshospitalet, Denmark
University Hospital Ostrava
McGill University
Anandasabapathy, Sharmila, M.D.
Ohio State University
Endo Pharmaceuticals
Telormedix SA
Materno-Perinatal Hospital of the State of Mexico
Spectrum Pharmaceuticals, Inc
Johannes Gutenberg University Mainz